Brief: Simulations Plus And The University Of Connecticut Awarded New FDA Contract To Accelerate The Development Of Long-Acting Injectable Products
26/10/2021 13:31
Oct 26 (Reuters) - Simulations Plus Inc SLP.O :
* SIMULATIONS PLUS AND THE UNIVERSITY OF CONNECTICUT AWARDED
NEW
FDA CONTRACT TO ACCELERATE THE DEVELOPMENT OF LONG-ACTING
INJECTABLE PRODUCTS
* SIMULATIONS PLUS INC - COLLABORATION WILL COMBINE NOVEL
EXPERIMENTAL TECHNIQUES AND MECHANISTIC MODELING STRATEGIES
Source text for Eikon: ID:nBw8Knbrja
Further company coverage: SLP.O
Recent news on Simulations Plus
See all newsBrief: Simulations Plus Altaris To Pay $26 Million Termination Fee To Co If Merger Agreement Terminated
NASDAQ RESUMED AT 09:55 AM
Brief: Simulations Plus To Be Acquired By Altaris For Approximately $375 Million
NASDAQ TRADE HALT HALT NEWS PENDING AT 08:55 AM
Simulations Plus Q2 results beat expectations but lowers annual profit forecast on tax rate jump